UnitedHealth Group Incorporated (UNH)
Can UNH's AI-Powered Virtual Assistance Enhance Member Experience?
UnitedHealth's AI-powered virtual assistants aim to simplify claims, boost engagement and deliver faster, more intuitive healthcare support.
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
UNH Stock In 2026: Bull And Bear Case Scenarios
For UnitedHealth's stock, the Medical Care Ratio (MCR) serves as the most significant factor influencing core profitability. The unexpected rise in MCR from around 82% in 2022 to an anticipated 88% in 2025 has already provoked a substantial correction in stock prices.
UnitedHealth: Time To Buy This Healthcare Fortress
UnitedHealth Group is rated Buy, with the worst seemingly behind and a clear path to margin recovery and earnings growth from 2026 onward. UNH's 2025 headwinds - higher medical expense ratio, Medicare Advantage pressures, and regulatory scrutiny - are being addressed through repricing, plan exits, and portfolio optimization. Valuation remains compelling: UNH trades at multi-year low multiples, with intrinsic value estimated at $843.55 per share, implying 154% upside.
Is UnitedHealth's Valuation Dip & Divestment Diet a Real Buy Window?
UNH trades below its five-year median P/E as it navigates margin pressure, membership declines and strategic divestments.
UnitedHealth Group (UNH) Sees a More Significant Dip Than Broader Market: Some Facts to Know
UnitedHealth Group (UNH) closed at $323.21 in the latest trading session, marking a -1.99% move from the prior day.
UnitedHealth: Axing Another Distraction, Onto 2026
UnitedHealth Group Incorporated is positioned for a multi-year turnaround, with 2026 marking the inflection and 2027 expected to deliver significant margin expansion. UNH's exit from Latin America, including a $1 billion Banmedica sale, strengthens the balance sheet and supports dividends and future buybacks. Despite elevated medical cost ratios and recent earnings pressure, UNH's Q3 revenue grew 12.3%, and management raised 2025 EPS guidance to at least $16.25.
Mangione shown videos of UnitedHealthcare CEO killing in court
Luigi Mangione has watched surveillance videos of the killing of UnitedHealthcare CEO Brian Thompson at a court appearance.
UnitedHealth agrees to sell South American business to private equity firm Patria for $1 billion, sources say
UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria Investments for $1 billion, two sources with knowledge of the matter said on Sunday.
UNH Battles MCR, Optum Bandages: But the Real Wild Card is Washington
UnitedHealth grapples with a surging MCR as Optum's strength steadies results while Washington's policy moves loom large.
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
